TSX:WEED (Canopy Growth)

About WEED

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
  • Canopy Growth (TSX: WEED) Latest News

    Cannabis smoke
    Cannabis Stocks

    Have Cannabis Stocks Totally Gone Up in Smoke?

    Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

    Read more »

    Pot stocks are a riskier investment
    Cannabis Stocks

    Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

    Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

    Read more »

    A cannabis plant grows.
    Cannabis Stocks

    These Threats Facing Canopy Growth Stock Could Justify Selling it

    Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

    Read more »

    Pot stocks are a riskier investment
    Investing

    Canopy Growth Stock Is Down 69% Over the Past Year: Can It Ever Recover?

    Let's dive into what key factors drove Canopy Growth's (TSX:WEED) recent decline, and whether a recovery is in order.

    Read more »

    Medicinal research is conducted on cannabis.
    Stocks for Beginners

    This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

    This TSX stock continues to be one of the best long-term opportunities, if you're patient.

    Read more »

    Medicinal research is conducted on cannabis.
    Cannabis Stocks

    1 Cannabis Stock That’s My Speculative Sector Play

    The cannabis boom has come and gone, but this cannabis stock may still have a chance to rise higher.

    Read more »

    Worker tags plants at an industrial cannabis operation
    Cannabis Stocks

    Canopy Growth: Buy, Sell, or Hold in July 2025?

    Read this if you're still bagholding Canopy Growth in 2025.

    Read more »

    Stethoscope with dollar shaped cord
    Cannabis Stocks

    Best Stock to Buy Right Now: Bausch Health vs Canopy Growth?

    While both stocks are risky, Bausch Health is seeing operational momentum, while Canopy Growth is still struggling with losses.

    Read more »

    Worker checks cannabis flower in lab farm greenhouse
    Cannabis Stocks

    Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?

    Canopy Growth stock remains a high-risk investment in 2025 due to its weak balance sheet and volatile profit margins.

    Read more »

    Medicinal research is conducted on cannabis.
    Tech Stocks

    Buy the Dip, Eh? 3 Canadian Stocks to Scoop Up During This Correction

    Looking for value in a correction? Now could be the time to pick up these three Canadian stocks.

    Read more »

    a person watches a downward arrow crash through the floor
    Stocks for Beginners

    Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

    This growth stock was once a major winner, but can investors wait for more?

    Read more »

    a person watches a downward arrow crash through the floor
    Investing

    Plummet Alert: These 3 Stocks Have Fallen Too Far to Ignore

    These three TSX stocks have dropped to a point where they're not just valuable but oversold.

    Read more »